It is currently Mon May 04, 2015 5:20 pm

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Suggestion for grouping discussion on research areas

Just an idea - for technical research discussions we might want to start some headers for topics of ongoing research, like infectious causes, mitochondrial dysfunction, endocrine dysfunction, metabolism issues, etc. Different people have different areas or research that they focus on, and it can get detailed. We are all working over different aspects of a very big elephant. So much get posted under "general discussion" and I can't remember the threads or where to go ...
Read more : Suggestion for grouping discussion on research areas | Views : 902 | Replies : 2 | Forum : General Discussion


ACTS

Read more : ACTS | Views : 1174 | Replies : 0 | Forum : Drug Pipeline


Rituximab

Read more : Rituximab | Views : 1343 | Replies : 0 | Forum : Drug Pipeline


Tysabri Efficacy

Whether you believe Tysabri should come back or not, it is useful to understand the drug's efficacy. Elan did a presentation to an investor conference today, and there are some fascinating slides which illustrate the drug's effectiveness. The information is from the AFFIRM two year trial which compared Tysabri to placebo:

RELAPSES:
66% reduction in relapse rate in Year 1
67% reduction in relapse rate over Two Years
http://www.tixx.com/jpm2006/target14.html ...
Read more : Tysabri Efficacy | Views : 1914 | Replies : 3 | Forum : Tysabri (Antegren or Natalizumab)


Rituxan Phase III for PPMS

I thought this was a typo a week or two ago when I saw mention of the latest Rituxan trial for PPMS being a Phase III trial, but this exerpt from a press release today says it again, so I guess it's not a typo.



Genentech Announces Full Year and Fourth Quarter 2005 Results

Tuesday January 10, 4:29 pm ET

Record Annual Revenues of $6.6 Billion Drive Year-Over-Year Non-GAAP EPS Growth of 54 Percent

SOUTH ...
Read more : Rituxan Phase III for PPMS | Views : 1607 | Replies : 0 | Forum : Drug Pipeline


Advice on Supplements

Hello,

I am trying to add supplements to my diet that will benefit my health. Currently I am taking Copaxone, a multi-vitamin and cod liver oil.
I was wondering if anyone could recommend anything additional that may help me. I have been reading up on different supplements but there are so many I don't know where to start. If you could recommend your favorite supplements and tell me how they have helped you I would ...
Read more : Advice on Supplements | Views : 2897 | Replies : 8 | Forum : Natural Approach


fatigue

hey everyone,
can anyone give me a couple of suggestions to help with fatigue.i been having a heck of a time with the being tired all the time..no matter how much i rest take naps go to bed early i just cant seem to be rested or more my self....i thought i had experienced fatgue when my kids were babys and colicy.. but that was nothing compared to what i have now..i was just wondering ...
Read more : fatigue | Views : 1950 | Replies : 10 | Forum : General Discussion


Where are most of the patients on LDN?

I went to meeting last night and no one had ever heard of LDN. I had not either until looking at this site. Where are you all located? I am in Southeastern USA and want to know if there are others in the USA or is this a Canada or England thing?
Read more : Where are most of the patients on LDN? | Views : 3083 | Replies : 8 | Forum : Low Dose Naltrexone


Robbie: Why did you go off the LDN??

I'm sorry if you have already posted this info but I have not had a chance to check in here for a while but why did you go off the LDN at all?
Read more : Robbie: Why did you go off the LDN?? | Views : 2649 | Replies : 3 | Forum : Low Dose Naltrexone


HP184

Here's a drug (Sanofi-aventis' HP184) in the early stages that might be helpful for MS and other conditions.



Tireless quest for a cure, Lorenzo-style

Globe & Mail - January 9, 2006...

Of particular interest is a drug called HP184, a sodium and potassium channel blocker that has been tested on spinal cord patients. When Jacob's parents brought the drug, made by Sanofi-aventis, to the attention of doctors, none had heard of it.

"They're very proactive, ...
Read more : HP184 | Views : 2249 | Replies : 1 | Forum : Drug Pipeline


 

Login  •  Register


Statistics

Total posts 225186 • Total topics 23582 • Total members 14946


Contact us | Terms of Service